The University of Utah DBA Cyclotron Radiochemistry Lab, Huntsman Cancer InstituteSeptember 6, 2024

FDA 483 - The University of Utah DBA Cyclotron Radiochemistry Lab, Huntsman Cancer Institute - September 06, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore The University of Utah DBA Cyclotron Radiochemistry Lab, Huntsman Cancer Institute

Record Details

The University of Utah DBA Cyclotron Radiochemistry Lab, a PET Drug Manufacturer in Salt Lake City, UT, was cited for failing to follow its written quality assurance procedures. Specifically, the firm did not perform annual product reviews for Pylarify Injection and did not complete or timely sign off on reviews for FDG Fludeoxyglucose F18 Injection as required by its own SOP. This indicates a significant lapse in maintaining quality system compliance for its radiopharmaceutical drug manufacturing.

Company: The University of Utah DBA Cyclotron Radiochemistry Lab, Huntsman Cancer Institute
Inspection Date: September 6, 2024
Product Type: Drugs
Office: Denver District Office
Person: Joey V. Quitania (Public Affairs Specialist)

Open in Dashboard

ID · 3b551f5a-f667-43e2-a66b-ab4e21e2ae5e